A TNM classification for digestive endocrine tumors of midgut and hindgut: Proposals from the European Neuroendocrine Tumor Society (ENETS);Une classification TNM pour les tumeurs endocrines digestives de l'intestin moyen et postérieur: Propositions de l'European Neuroendocrine Tumor Society (2007)

Annales de Pathologie

Volumn 27, Issue 6, 2007, Pages 426-432

  Couvelard, Anne ^a   Scoazec, Jean Yves ^b,c  

^a BEAUJON HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Appendix; Digestive endocrine tumors; Hindgut; Immunohistochemistry; Ki67 index; Midgut; Neuroendocrine tumors; TNM classification

Indexed keywords

APPENDECTOMY; CANCER STAGING; COLON TUMOR; DISEASE CLASSIFICATION; ENDOCRINE TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE TUMOR; MIDGUT; RECTUM TUMOR; REVIEW; RISK ASSESSMENT;

EID: 42149127640     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0242-6498(07)71414-1     Document Type: Article

References (18)

1. Couvelard A, Scoazec JY. Proposal for a TNM classification of digestive (neuro)endocrine tumors: recommendations of the European Neuroendocrine Tumor Society (2006). Ann Pathol 2006;26:413-7.
2. Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395- 401.
3. Rindi G, Klöppel G, Couvelard A, Komminoth P, Körner M, Lopes JM, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007;451:757-62.
4. DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organisation Classification of Tumours : Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France, IARC Press, 2004.
5. Solcia E, Klöppel G, Sobin LH. Histological typing of endocrine tumours, 2nd edition. WHO International Classification of Tumours. Berlin: Springer, 2000;
6. Hamilton SR, Aaltonen LA. Eds. Pathology and Genetics. Tumours of the Digestive System. WHO Classification of Tumours. Lyon, IARC, 2000.
7. Rindi G, Couvelard A, Scoazec JY, Bordi C. Recommandations pratiques pour ĺvaluation de la malignité dans les tumeurs endocrines digestives. Ann Pathol 2005;25:487-98.
8. Sobin LH, Wittkind C (eds). TNM Classification of Malignant Tumours. Wiley-Liss, New York, 2002.
9. Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424.
10. Plöckinger U, Couvelard A, Falconi M, Sundin A, Salazar R, Christ E, et al. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma. Neuroendocrinology 2008;87:20-30.
11. McGory ML, Maggard MA, et al. Malignancies of the appendix: beyond case series reports. Dis Colon Rectum 2005 ;48:2264-71.
12. Fahy BN, Tang LH, Klimstra D, Wong WD, Guillem JG, Paty PB et al. Carcinoids of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol 2007;14:396-404.
13. La Rosa S, Rigoli E, Uccella S, Chiaravalli AM, Capella C. CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors. Virchows Arch 2004;445:248-54.
14. Sturm N, Rossi G, Lantuejoul S, Papotti M, Frachon S, Claraz C, et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002;33:175-82.
15. Agoff SN, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000;13:238-42.
16. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000;36:415- 20.
17. Jakobsen AM, Andersson P, Saglik G, Andersson E, Kölby L, Erickson JD, et al. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours. J Pathol 2001;195:463-72.
18. Kimura N, Sasano N. Prostate-specific acid phosphatase in carcinoid tumors. Virchows Arch A Pathol Anat Histopathol 1986;410:247-51.